nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamterene—CYP1A2—Estropipate—osteoporosis	0.184	0.53	CbGbCtD
Triamterene—Irreversible renal failure—Ergocalciferol—osteoporosis	0.133	0.203	CcSEcCtD
Triamterene—CYP1A2—Conjugated Estrogens—osteoporosis	0.0869	0.251	CbGbCtD
Triamterene—CYP1A2—Estradiol—osteoporosis	0.0763	0.22	CbGbCtD
Triamterene—Renal failure chronic—Ergocalciferol—osteoporosis	0.0464	0.0711	CcSEcCtD
Triamterene—Renal failure chronic—Calcitriol—osteoporosis	0.028	0.0429	CcSEcCtD
Triamterene—Azotaemia—Ergocalciferol—osteoporosis	0.0235	0.0359	CcSEcCtD
Triamterene—Renal failure chronic—Zoledronate—osteoporosis	0.0205	0.0314	CcSEcCtD
Triamterene—Azotaemia—Ibandronate—osteoporosis	0.0145	0.0222	CcSEcCtD
Triamterene—Calculus of kidney—Calcitriol—osteoporosis	0.0115	0.0176	CcSEcCtD
Triamterene—Azotaemia—Pamidronate—osteoporosis	0.0113	0.0174	CcSEcCtD
Triamterene—Azotaemia—Zoledronate—osteoporosis	0.0104	0.0159	CcSEcCtD
Triamterene—Nephrolithiasis—Alendronate—osteoporosis	0.00985	0.0151	CcSEcCtD
Triamterene—Nephrolithiasis—Calcitriol—osteoporosis	0.00939	0.0144	CcSEcCtD
Triamterene—Nephrolithiasis—Risedronate—osteoporosis	0.0079	0.0121	CcSEcCtD
Triamterene—Tubulointerstitial nephritis—Pamidronate—osteoporosis	0.00789	0.0121	CcSEcCtD
Triamterene—Blood urea increased—Calcitriol—osteoporosis	0.00712	0.0109	CcSEcCtD
Triamterene—Photosensitivity—Alendronate—osteoporosis	0.00655	0.01	CcSEcCtD
Triamterene—Renal failure acute—Ibandronate—osteoporosis	0.00606	0.00928	CcSEcCtD
Triamterene—Hyperkalaemia—Pamidronate—osteoporosis	0.00593	0.00908	CcSEcCtD
Triamterene—Blood urea increased—Pamidronate—osteoporosis	0.0057	0.00873	CcSEcCtD
Triamterene—Hyperkalaemia—Zoledronate—osteoporosis	0.00542	0.0083	CcSEcCtD
Triamterene—Blood urea increased—Zoledronate—osteoporosis	0.00521	0.00797	CcSEcCtD
Triamterene—Blood urea increased—Conjugated Estrogens—osteoporosis	0.00501	0.00768	CcSEcCtD
Triamterene—Renal failure acute—Pamidronate—osteoporosis	0.00475	0.00727	CcSEcCtD
Triamterene—Photosensitivity reaction—Alendronate—osteoporosis	0.00453	0.00694	CcSEcCtD
Triamterene—Renal failure acute—Zoledronate—osteoporosis	0.00434	0.00664	CcSEcCtD
Triamterene—Renal failure acute—Conjugated Estrogens—osteoporosis	0.00418	0.00639	CcSEcCtD
Triamterene—Hypokalaemia—Pamidronate—osteoporosis	0.00399	0.00611	CcSEcCtD
Triamterene—Hypersensitivity—Calcium Acetate—osteoporosis	0.00372	0.0057	CcSEcCtD
Triamterene—Hypokalaemia—Zoledronate—osteoporosis	0.00364	0.00558	CcSEcCtD
Triamterene—Asthenia—Calcium Acetate—osteoporosis	0.00362	0.00555	CcSEcCtD
Triamterene—Hypokalaemia—Conjugated Estrogens—osteoporosis	0.00351	0.00537	CcSEcCtD
Triamterene—Diarrhoea—Calcium Acetate—osteoporosis	0.00345	0.00529	CcSEcCtD
Triamterene—Dizziness—Calcium Acetate—osteoporosis	0.00334	0.00511	CcSEcCtD
Triamterene—Vomiting—Calcium Acetate—osteoporosis	0.00321	0.00492	CcSEcCtD
Triamterene—Asthenia—Ergocalciferol—osteoporosis	0.0032	0.0049	CcSEcCtD
Triamterene—Nausea—Calcium Acetate—osteoporosis	0.003	0.00459	CcSEcCtD
Triamterene—Anaphylactic shock—Estropipate—osteoporosis	0.00287	0.00439	CcSEcCtD
Triamterene—Dry mouth—Ibandronate—osteoporosis	0.00281	0.0043	CcSEcCtD
Triamterene—Anaphylactic shock—Ibandronate—osteoporosis	0.00275	0.00421	CcSEcCtD
Triamterene—Dry mouth—Calcitriol—osteoporosis	0.00275	0.00421	CcSEcCtD
Triamterene—Thrombocytopenia—Raloxifene—osteoporosis	0.00272	0.00416	CcSEcCtD
Triamterene—Anaphylactic shock—Calcitriol—osteoporosis	0.00269	0.00412	CcSEcCtD
Triamterene—Nausea—Ergocalciferol—osteoporosis	0.00265	0.00406	CcSEcCtD
Triamterene—Fatigue—Estropipate—osteoporosis	0.00247	0.00379	CcSEcCtD
Triamterene—Hypersensitivity—Etidronic acid—osteoporosis	0.00244	0.00374	CcSEcCtD
Triamterene—Photosensitivity reaction—Estradiol—osteoporosis	0.00243	0.00373	CcSEcCtD
Triamterene—Fatigue—Ibandronate—osteoporosis	0.00237	0.00363	CcSEcCtD
Triamterene—Jaundice—Estradiol—osteoporosis	0.00232	0.00355	CcSEcCtD
Triamterene—Dry mouth—Risedronate—osteoporosis	0.00231	0.00354	CcSEcCtD
Triamterene—Diarrhoea—Etidronic acid—osteoporosis	0.00227	0.00347	CcSEcCtD
Triamterene—Anaphylactic shock—Pamidronate—osteoporosis	0.00215	0.0033	CcSEcCtD
Triamterene—Hypersensitivity—Estropipate—osteoporosis	0.00211	0.00324	CcSEcCtD
Triamterene—Thrombocytopenia—Pamidronate—osteoporosis	0.00211	0.00323	CcSEcCtD
Triamterene—Vomiting—Etidronic acid—osteoporosis	0.00211	0.00323	CcSEcCtD
Triamterene—Rash—Etidronic acid—osteoporosis	0.00209	0.0032	CcSEcCtD
Triamterene—Dermatitis—Etidronic acid—osteoporosis	0.00209	0.0032	CcSEcCtD
Triamterene—Hypersensitivity—Alendronate—osteoporosis	0.00208	0.00319	CcSEcCtD
Triamterene—Headache—Etidronic acid—osteoporosis	0.00208	0.00318	CcSEcCtD
Triamterene—Asthenia—Estropipate—osteoporosis	0.00206	0.00315	CcSEcCtD
Triamterene—Asthenia—Alendronate—osteoporosis	0.00203	0.0031	CcSEcCtD
Triamterene—Hypersensitivity—Ibandronate—osteoporosis	0.00203	0.0031	CcSEcCtD
Triamterene—Dry mouth—Zoledronate—osteoporosis	0.00201	0.00307	CcSEcCtD
Triamterene—Fatigue—Ethinyl Estradiol—osteoporosis	0.002	0.00307	CcSEcCtD
Triamterene—Hypersensitivity—Calcitriol—osteoporosis	0.00198	0.00304	CcSEcCtD
Triamterene—Asthenia—Ibandronate—osteoporosis	0.00197	0.00302	CcSEcCtD
Triamterene—Nausea—Etidronic acid—osteoporosis	0.00197	0.00301	CcSEcCtD
Triamterene—Anaphylactic shock—Zoledronate—osteoporosis	0.00197	0.00301	CcSEcCtD
Triamterene—Diarrhoea—Estropipate—osteoporosis	0.00196	0.003	CcSEcCtD
Triamterene—Fatigue—Risedronate—osteoporosis	0.00195	0.00299	CcSEcCtD
Triamterene—Diarrhoea—Alendronate—osteoporosis	0.00193	0.00296	CcSEcCtD
Triamterene—Asthenia—Calcitriol—osteoporosis	0.00193	0.00296	CcSEcCtD
Triamterene—Thrombocytopenia—Zoledronate—osteoporosis	0.00193	0.00295	CcSEcCtD
Triamterene—Diarrhoea—Raloxifene—osteoporosis	0.0019	0.00291	CcSEcCtD
Triamterene—Dizziness—Estropipate—osteoporosis	0.0019	0.0029	CcSEcCtD
Triamterene—Anaphylactic shock—Conjugated Estrogens—osteoporosis	0.0019	0.0029	CcSEcCtD
Triamterene—Diarrhoea—Ibandronate—osteoporosis	0.00188	0.00288	CcSEcCtD
Triamterene—Dizziness—Alendronate—osteoporosis	0.00187	0.00286	CcSEcCtD
Triamterene—Fatigue—Pamidronate—osteoporosis	0.00186	0.00284	CcSEcCtD
Triamterene—Diarrhoea—Calcitriol—osteoporosis	0.00184	0.00282	CcSEcCtD
Triamterene—Dizziness—Raloxifene—osteoporosis	0.00184	0.00281	CcSEcCtD
Triamterene—Vomiting—Estropipate—osteoporosis	0.00182	0.00279	CcSEcCtD
Triamterene—Dizziness—Ibandronate—osteoporosis	0.00182	0.00278	CcSEcCtD
Triamterene—Rash—Estropipate—osteoporosis	0.00181	0.00277	CcSEcCtD
Triamterene—Dermatitis—Estropipate—osteoporosis	0.00181	0.00277	CcSEcCtD
Triamterene—Headache—Estropipate—osteoporosis	0.0018	0.00275	CcSEcCtD
Triamterene—Vomiting—Alendronate—osteoporosis	0.0018	0.00275	CcSEcCtD
Triamterene—Rash—Alendronate—osteoporosis	0.00178	0.00273	CcSEcCtD
Triamterene—Dermatitis—Alendronate—osteoporosis	0.00178	0.00272	CcSEcCtD
Triamterene—Headache—Alendronate—osteoporosis	0.00177	0.00271	CcSEcCtD
Triamterene—Vomiting—Raloxifene—osteoporosis	0.00177	0.0027	CcSEcCtD
Triamterene—Rash—Raloxifene—osteoporosis	0.00175	0.00268	CcSEcCtD
Triamterene—Dermatitis—Raloxifene—osteoporosis	0.00175	0.00268	CcSEcCtD
Triamterene—Vomiting—Ibandronate—osteoporosis	0.00175	0.00268	CcSEcCtD
Triamterene—Headache—Raloxifene—osteoporosis	0.00174	0.00266	CcSEcCtD
Triamterene—Rash—Ibandronate—osteoporosis	0.00173	0.00265	CcSEcCtD
Triamterene—Dermatitis—Ibandronate—osteoporosis	0.00173	0.00265	CcSEcCtD
Triamterene—Headache—Ibandronate—osteoporosis	0.00172	0.00264	CcSEcCtD
Triamterene—Hypersensitivity—Ethinyl Estradiol—osteoporosis	0.00171	0.00262	CcSEcCtD
Triamterene—Vomiting—Calcitriol—osteoporosis	0.00171	0.00262	CcSEcCtD
Triamterene—Nausea—Estropipate—osteoporosis	0.0017	0.00261	CcSEcCtD
Triamterene—Rash—Calcitriol—osteoporosis	0.0017	0.0026	CcSEcCtD
Triamterene—Fatigue—Zoledronate—osteoporosis	0.0017	0.0026	CcSEcCtD
Triamterene—Dermatitis—Calcitriol—osteoporosis	0.0017	0.0026	CcSEcCtD
Triamterene—Headache—Calcitriol—osteoporosis	0.00169	0.00258	CcSEcCtD
Triamterene—Nausea—Alendronate—osteoporosis	0.00168	0.00257	CcSEcCtD
Triamterene—Hypersensitivity—Risedronate—osteoporosis	0.00167	0.00256	CcSEcCtD
Triamterene—Asthenia—Ethinyl Estradiol—osteoporosis	0.00167	0.00255	CcSEcCtD
Triamterene—Nausea—Raloxifene—osteoporosis	0.00165	0.00253	CcSEcCtD
Triamterene—Fatigue—Conjugated Estrogens—osteoporosis	0.00163	0.0025	CcSEcCtD
Triamterene—Nausea—Ibandronate—osteoporosis	0.00163	0.0025	CcSEcCtD
Triamterene—Asthenia—Risedronate—osteoporosis	0.00163	0.00249	CcSEcCtD
Triamterene—Nausea—Calcitriol—osteoporosis	0.0016	0.00245	CcSEcCtD
Triamterene—Diarrhoea—Ethinyl Estradiol—osteoporosis	0.00159	0.00244	CcSEcCtD
Triamterene—Hypersensitivity—Pamidronate—osteoporosis	0.00159	0.00243	CcSEcCtD
Triamterene—Diarrhoea—Risedronate—osteoporosis	0.00155	0.00237	CcSEcCtD
Triamterene—Dry mouth—Estradiol—osteoporosis	0.00155	0.00237	CcSEcCtD
Triamterene—Asthenia—Pamidronate—osteoporosis	0.00155	0.00237	CcSEcCtD
Triamterene—Dizziness—Ethinyl Estradiol—osteoporosis	0.00154	0.00235	CcSEcCtD
Triamterene—Anaphylactic shock—Estradiol—osteoporosis	0.00152	0.00232	CcSEcCtD
Triamterene—Dizziness—Risedronate—osteoporosis	0.0015	0.00229	CcSEcCtD
Triamterene—Vomiting—Ethinyl Estradiol—osteoporosis	0.00148	0.00226	CcSEcCtD
Triamterene—Diarrhoea—Pamidronate—osteoporosis	0.00147	0.00226	CcSEcCtD
Triamterene—Rash—Ethinyl Estradiol—osteoporosis	0.00147	0.00224	CcSEcCtD
Triamterene—Dermatitis—Ethinyl Estradiol—osteoporosis	0.00146	0.00224	CcSEcCtD
Triamterene—Headache—Ethinyl Estradiol—osteoporosis	0.00146	0.00223	CcSEcCtD
Triamterene—Hypersensitivity—Zoledronate—osteoporosis	0.00145	0.00222	CcSEcCtD
Triamterene—Vomiting—Risedronate—osteoporosis	0.00144	0.00221	CcSEcCtD
Triamterene—Rash—Risedronate—osteoporosis	0.00143	0.00219	CcSEcCtD
Triamterene—Dermatitis—Risedronate—osteoporosis	0.00143	0.00219	CcSEcCtD
Triamterene—Dizziness—Pamidronate—osteoporosis	0.00142	0.00218	CcSEcCtD
Triamterene—Headache—Risedronate—osteoporosis	0.00142	0.00217	CcSEcCtD
Triamterene—Asthenia—Zoledronate—osteoporosis	0.00141	0.00216	CcSEcCtD
Triamterene—Hypersensitivity—Conjugated Estrogens—osteoporosis	0.0014	0.00214	CcSEcCtD
Triamterene—Nausea—Ethinyl Estradiol—osteoporosis	0.00138	0.00211	CcSEcCtD
Triamterene—Vomiting—Pamidronate—osteoporosis	0.00137	0.0021	CcSEcCtD
Triamterene—Asthenia—Conjugated Estrogens—osteoporosis	0.00136	0.00208	CcSEcCtD
Triamterene—Rash—Pamidronate—osteoporosis	0.00136	0.00208	CcSEcCtD
Triamterene—Dermatitis—Pamidronate—osteoporosis	0.00136	0.00208	CcSEcCtD
Triamterene—Headache—Pamidronate—osteoporosis	0.00135	0.00207	CcSEcCtD
Triamterene—Diarrhoea—Zoledronate—osteoporosis	0.00135	0.00206	CcSEcCtD
Triamterene—Nausea—Risedronate—osteoporosis	0.00135	0.00206	CcSEcCtD
Triamterene—Fatigue—Estradiol—osteoporosis	0.00131	0.002	CcSEcCtD
Triamterene—Dizziness—Zoledronate—osteoporosis	0.0013	0.00199	CcSEcCtD
Triamterene—Diarrhoea—Conjugated Estrogens—osteoporosis	0.0013	0.00199	CcSEcCtD
Triamterene—Nausea—Pamidronate—osteoporosis	0.00128	0.00196	CcSEcCtD
Triamterene—Dizziness—Conjugated Estrogens—osteoporosis	0.00125	0.00192	CcSEcCtD
Triamterene—Vomiting—Zoledronate—osteoporosis	0.00125	0.00192	CcSEcCtD
Triamterene—Rash—Zoledronate—osteoporosis	0.00124	0.0019	CcSEcCtD
Triamterene—Dermatitis—Zoledronate—osteoporosis	0.00124	0.0019	CcSEcCtD
Triamterene—Headache—Zoledronate—osteoporosis	0.00123	0.00189	CcSEcCtD
Triamterene—Vomiting—Conjugated Estrogens—osteoporosis	0.0012	0.00184	CcSEcCtD
Triamterene—Rash—Conjugated Estrogens—osteoporosis	0.00119	0.00183	CcSEcCtD
Triamterene—Dermatitis—Conjugated Estrogens—osteoporosis	0.00119	0.00183	CcSEcCtD
Triamterene—Headache—Conjugated Estrogens—osteoporosis	0.00119	0.00182	CcSEcCtD
Triamterene—Nausea—Zoledronate—osteoporosis	0.00117	0.00179	CcSEcCtD
Triamterene—Nausea—Conjugated Estrogens—osteoporosis	0.00113	0.00172	CcSEcCtD
Triamterene—Hypersensitivity—Estradiol—osteoporosis	0.00112	0.00171	CcSEcCtD
Triamterene—Asthenia—Estradiol—osteoporosis	0.00109	0.00167	CcSEcCtD
Triamterene—Diarrhoea—Estradiol—osteoporosis	0.00104	0.00159	CcSEcCtD
Triamterene—Dizziness—Estradiol—osteoporosis	0.001	0.00154	CcSEcCtD
Triamterene—Vomiting—Estradiol—osteoporosis	0.000964	0.00148	CcSEcCtD
Triamterene—Rash—Estradiol—osteoporosis	0.000956	0.00146	CcSEcCtD
Triamterene—Dermatitis—Estradiol—osteoporosis	0.000955	0.00146	CcSEcCtD
Triamterene—Headache—Estradiol—osteoporosis	0.00095	0.00145	CcSEcCtD
Triamterene—Nausea—Estradiol—osteoporosis	0.000901	0.00138	CcSEcCtD
